Showing results (91-100 of 2,902) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|May 7, 2005
Inefficient killing of quiescent human epithelial cells by replicating adenoviruses: potential implications for their use as oncolytic agentsMei Ting Vaillancourt, Isabella Atencio, Erlinda Quijano, et al.Cancer Gene Therapy|March 12, 2005
Avian adenovirus vector CELO-TK displays anticancer activity in human cancer cells and suppresses established murine melanoma tumorsElena V Shashkova, Lubov V Cherenova, Dmitry B Kazansky, et al.Cancer Gene Therapy|April 2, 2005
Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancerTerry Lichtor, Roberta P Glick, Henry Lin, et al.Cancer Gene Therapy|April 2, 2005
Small interfering RNA targeting Raf-1 inhibits tumor growth in vitro and in vivoQixin Leng, Archibald James MixsonCancer Gene Therapy|April 2, 2005
Effects of Onyx-015 among metastatic colorectal cancer patients that have failed prior treatment with 5-FU/leucovorinTony R Reid, Scott Freeman, Leonard Post, et al.Cancer Gene Therapy|September 11, 2004
Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1Loren W Noblitt, Dinesh S Bangari, Shruti Shukla, et al.Cancer Gene Therapy|September 11, 2004
Immune properties of recombinant vaccinia virus encoding CD154 (CD40L) are determined by expression of virally encoded CD40L and the presence of CD40L protein in viral particlesMichal Bereta, Joanna Bereta, Jonas Park, et al.Cancer Gene Therapy|October 23, 2004
Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancerMark A Rochester, Johann Riedemann, Giles O Hellawell, et al.Cancer Gene Therapy|October 23, 2004
A novel fusion suicide gene yeast CDglyTK plays a role in radio-gene therapy of nasopharyngeal carcinomaKun Xia, Desheng Liang, Aifa Tang, et al.Cancer Gene Therapy|October 30, 2004
In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancerSunil Sudarshan, David H Holman, Marc L Hyer, et al.Pageof 291